Notice: This company has been marked as potentially delisted and may not be actively trading. Abiomed (ABMD) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period ‘We think in decades’: J&J’s $30B spending spree may not be overApril 17, 2024 | finance.yahoo.comFDA issues alert on Abiomed heart pump associated with 49 deathsApril 3, 2024 | bizjournals.comAbiomed Heart Pumps Linked to 49 DeathsApril 1, 2024 | msn.comUS FDA classifies corrections to instructions for Abiomed's blood pumps as most seriousMarch 21, 2024 | yahoo.comUS FDA classifies recall of Abiomed's blood pumps as most seriousMarch 21, 2024 | reuters.comWill Johnson & Johnson Stock Rebound To Its Pre-Inflation Shock Highs Of $185?March 19, 2024 | forbes.comAbiomed Inc's Pipeline Analysis for 2023 Reveals Clinical Advancement in Circulatory Support TechnologyJanuary 16, 2024 | finance.yahoo.comAbiomed to Highlight Data Analysis Identifying Complex Clinical Profile of Patients Receiving Impella-Supported HRPCI at TCT SymposiumOctober 23, 2023 | finance.yahoo.comFDA warns Abiomed over device classificationOctober 14, 2023 | bizjournals.comJ&J's Abiomed unit recalls Impella 5.5 heart pumps over safety concernsJune 7, 2023 | msn.comAbiomed, Inc. (ABMD) stock price, news, quote & history – Yahoo FinanceMay 1, 2023 | uk.finance.yahoo.comWant to Retire a Millionaire? 2 Stocks to Buy NowMarch 21, 2023 | stocknews.com3 Stocks That Could Deliver Healthy Returns in 2023March 17, 2023 | stocknews.comThis Big Pharma Stock Is a Clear Buy in 2023March 13, 2023 | stocknews.comAbiomed, Inc. (ABMD) stock historical prices & data – Yahoo FinanceMarch 12, 2023 | uk.finance.yahoo.com3 Powerhouse Stocks to Buy in 2023March 10, 2023 | stocknews.com3 Hot Dividend Stocks to Buy Now and Hold ForeverMarch 6, 2023 | stocknews.comAbiomed, Inc. (ABMD) Stock Historical Prices & Data - Yahoo FinanceMarch 4, 2023 | finance.yahoo.com2 No-Brainer Warren Buffett Stocks to Buy in 2023March 2, 2023 | stocknews.com3 S&P 500 Stocks to Buy If You Like WinningMarch 1, 2023 | stocknews.com3 Stocks to Help Grow Your Portfolio Over the Next DecadeFebruary 28, 2023 | stocknews.comAbiomed, Inc. (NASDAQ:ABMD) Shares Acquired by Nisa Investment Advisors LLCNisa Investment Advisors LLC grew its stake in Abiomed, Inc. (NASDAQ:ABMD - Get Rating) by 6.5% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,391 shares of the medical equipment provider's stock after pFebruary 6, 2023 | marketbeat.comIllinois Municipal Retirement Fund Has $4.51 Million Stock Position in Abiomed, Inc. (NASDAQ:ABMD)Illinois Municipal Retirement Fund boosted its stake in shares of Abiomed, Inc. (NASDAQ:ABMD - Get Rating) by 130.9% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 18,362 shares of the medical equipment provider's stock after buying an additional 10,408January 23, 2023 | marketbeat.comGeneva Capital Management LLC Has $21.91 Million Holdings in Abiomed, Inc. (NASDAQ:ABMD)Geneva Capital Management LLC decreased its holdings in Abiomed, Inc. (NASDAQ:ABMD - Get Rating) by 1.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 89,179 shares of the medical equipment provider's stock after sellJanuary 16, 2023 | marketbeat.comAbiomed, Inc. (NASDAQ:ABMD) Given Average Recommendation of "Hold" by AnalystsAbiomed, Inc. (NASDAQ:ABMD - Get Rating) has received an average recommendation of "Hold" from the eight ratings firms that are presently covering the stock, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a hold rating and one has given a buy rating to theDecember 26, 2022 | marketbeat.com3 Reasons to Retain Abiomed (ABMD) Stock in Your PortfolioDecember 22, 2022 | finance.yahoo.comTrading was temporarily halted for "ABMD" at 07:12 PM with a stated reason of "News pending."December 22, 2022 | marketbeat.comStock Traders Buy Large Volume of Put Options on Abiomed (NASDAQ:ABMD)Abiomed, Inc. (NASDAQ:ABMD - Get Rating) was the target of some unusual options trading on Wednesday. Stock traders acquired 4,396 put options on the company. This represents an increase of approximately 329% compared to the typical volume of 1,024 put options.December 21, 2022 | marketbeat.comFDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical TrialDecember 21, 2022 | finance.yahoo.comAbiomed, Inc. (NASDAQ:ABMD) Sees Large Growth in Short InterestAbiomed, Inc. (NASDAQ:ABMD - Get Rating) saw a large growth in short interest in November. As of November 30th, there was short interest totalling 753,600 shares, a growth of 12.9% from the November 15th total of 667,400 shares. Based on an average daily trading volume, of 912,600 shares, the short-interest ratio is presently 0.8 days. Approximately 1.7% of the shares of the stock are sold short.December 16, 2022 | marketbeat.comAbiomed, Inc. (NASDAQ:ABMD) Sees Large Growth in Short InterestAbiomed, Inc. (NASDAQ:ABMD - Get Rating) was the target of a significant growth in short interest in November. As of November 30th, there was short interest totalling 753,600 shares, a growth of 12.9% from the November 15th total of 667,400 shares. Currently, 1.7% of the company's stock are sold short. Based on an average daily trading volume, of 912,600 shares, the days-to-cover ratio is presently 0.8 days.December 16, 2022 | marketbeat.com10 Best Performing Stocks in NovemberDecember 13, 2022 | finance.yahoo.comCan Pfizer, Johnson & Johnson Continue Outperforming the Index? (ABMD)Large-cap pharmaceuticals Pfizer and Johnson & Johnson are outperforming the broader market in the past year, particularly in the past three months.December 13, 2022 | marketbeat.comThis Monster Dividend Stock Isn't Done GrowingDecember 8, 2022 | finance.yahoo.comFirst Patients in the World Treated with Impella RP Flex with SmartAssistDecember 5, 2022 | finance.yahoo.comWhy Is Abiomed (ABMD) Up 1.2% Since Last Earnings Report?December 1, 2022 | finance.yahoo.comAbiomed, Inc. (NASDAQ:ABMD) Given Average Rating of "Hold" by AnalystsShares of Abiomed, Inc. (NASDAQ:ABMD - Get Rating) have been assigned a consensus rating of "Hold" from the eight analysts that are covering the firm, Marketbeat Ratings reports. Seven investment analysts have rated the stock with a hold rating and one has given a buy rating to the company. The aDecember 1, 2022 | marketbeat.comAbiomed, Inc. (NASDAQ:ABMD) Sees Large Decrease in Short InterestAbiomed, Inc. (NASDAQ:ABMD - Get Rating) was the target of a significant decrease in short interest during the month of November. As of November 15th, there was short interest totalling 667,400 shares, a decrease of 67.9% from the October 31st total of 2,080,000 shares. Based on an average trading volume of 833,800 shares, the short-interest ratio is currently 0.8 days. Currently, 1.5% of the company's shares are sold short.November 28, 2022 | marketbeat.comZacks Research Analysts Decrease Earnings Estimates for Abiomed, Inc. (NASDAQ:ABMD)Abiomed, Inc. (NASDAQ:ABMD - Get Rating) - Equities researchers at Zacks Research reduced their Q3 2023 earnings per share estimates for shares of Abiomed in a note issued to investors on Tuesday, November 22nd. Zacks Research analyst D. Dey now anticipates that the medical equipment provider wilNovember 24, 2022 | marketbeat.comZacks Research Equities Analysts Cut Earnings Estimates for Abiomed, Inc. (NASDAQ:ABMD)Abiomed, Inc. (NASDAQ:ABMD - Get Rating) - Stock analysts at Zacks Research reduced their Q1 2024 earnings estimates for Abiomed in a research report issued on Tuesday, November 15th. Zacks Research analyst D. Dey now forecasts that the medical equipment provider will post earnings of $1.21 per sNovember 18, 2022 | marketbeat.comAbiomed, Inc. (NASDAQ:ABMD) Short Interest Up 5.6% in OctoberAbiomed, Inc. (NASDAQ:ABMD - Get Rating) was the target of a large growth in short interest in October. As of October 31st, there was short interest totalling 2,080,000 shares, a growth of 5.6% from the October 15th total of 1,970,000 shares. Currently, 4.7% of the shares of the company are sold short. Based on an average daily trading volume, of 547,300 shares, the short-interest ratio is presently 3.8 days.November 16, 2022 | marketbeat.comS&P 500 Component DexCom Set For Further Price, Earnings Growth (ABMD)Glucose monitor maker DexCom surged 19% after its Q3 report, and shares are holding those gains. Wall Street sees more growth ahead in 2023.November 13, 2022 | marketbeat.comJohnson & Johnson Could Level Up With Its $16.8 Billion Purchase of AbiomedNovember 10, 2022 | finance.yahoo.comInsider Selling: Abiomed, Inc. (NASDAQ:ABMD) VP Sells 2,000 Shares of StockAbiomed, Inc. (NASDAQ:ABMD - Get Rating) VP Marc A. Began sold 2,000 shares of the company's stock in a transaction dated Friday, November 4th. The stock was sold at an average price of $373.71, for a total transaction of $747,420.00. Following the completion of the transaction, the vice president now owns 13,785 shares in the company, valued at $5,151,592.35. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.November 8, 2022 | marketbeat.comAbiomed, Inc. (NASDAQ:ABMD) Receives Average Recommendation of "Hold" from AnalystsAbiomed, Inc. (NASDAQ:ABMD - Get Rating) has earned a consensus recommendation of "Hold" from the eight research firms that are currently covering the stock, Marketbeat.com reports. Seven analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average 1November 6, 2022 | marketbeat.comJohnson & Johnson's Big Purchase, Amazon's New Moves, and MoreNovember 5, 2022 | finance.yahoo.comAbiomed Sees Unusually High Options Volume (NASDAQ:ABMD)Abiomed, Inc. (NASDAQ:ABMD - Get Rating) was the recipient of some unusual options trading activity on Wednesday. Stock traders acquired 2,874 put options on the company. This is an increase of 1,155% compared to the average daily volume of 229 put options.November 2, 2022 | marketbeat.comAbiomed (NASDAQ:ABMD) Upgraded to Equal Weight by Morgan StanleyMorgan Stanley raised shares of Abiomed from an "underweight" rating to an "equal weight" rating in a report on Wednesday.November 2, 2022 | marketbeat.comJ&J Agrees to Buy Heart-Device Maker Abiomed for $16.6 BillionNovember 1, 2022 | wsj.comAbiomed (ABMD) Q2 Earnings Top Estimates, Margins DownNovember 1, 2022 | finance.yahoo.com Get Abiomed News Delivered to You Automatically Sign up to receive the latest news and ratings for ABMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners… Claim your FREE 2024 Gold Guide ABMD Media Mentions By Week ABMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABMD News Sentiment▼0.440.46▲Average Medical News Sentiment ABMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABMD Articles This Week▼00▲ABMD Articles Average Week Get Abiomed News Delivered to You Automatically Sign up to receive the latest news and ratings for ABMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NovoCure News Today Nevro News Today Becton, Dickinson and Company News Today Edwards Lifesciences News Today ResMed News Today IDEXX Laboratories News Today DexCom News Today STERIS News Today Insulet News Today Hologic News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ABMD) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abiomed, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Abiomed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ABMD Stock Alerts